BioNTech to Lay Off 1,860 Employees

German biotechnology company BioNTech has announced a decision to lay off 1,860 employees worldwide. The company said the move is aimed at reducing excess capacity and cutting costs. It also disclosed that several manufacturing facilities will be closed. Following a decline in demand after the COVID‑19 vaccine rollout, BioNTech is pursuing a restructuring process to enhance operational efficiency. The layoffs are estimated to affect roughly 10% of the firm’s global workforce. Company officials stated that the decision is part of a long‑term growth strategy and will enable more efficient use of resources. BioNTech will continue its research and development efforts in vaccine development and cancer therapies. This is not investment advice.

📊 BNT — Piyasa Yorumu

▼ down · 55%

The recent decision by BioNTech to terminate 1,860 employees may cast a negative impression on the company's operational efficiency and investor confidence. In the cryptocurrency market, such news typically triggers short‑term selling pressure. Technical indicators show that the price remains above the 20‑ and 50‑day moving averages, yet the MACD is below its signal line and the RSI sits at a moderate level, which could be interpreted as a potential correction signal. A modest decline in price over the next one to three days is likely, although the overall trend may still remain bullish. Consequently, the short‑term move is more likely to be negative, but a sharp drop is not expected.

RSI 14

57.4

MACD

0.00

24h Δ

1.64%

Canlı Grafikler